Latest Breaking News On - F markus leweke university of sydney - Page 1 : comparemela.com

PreveCeutical & Endosane Announces Innovative Preclinical Approaches to Assess Brain Availability of CBD And Pharmacologically Relevant Doses Following Intranasal CBD Application

/PRNewswire/ - PreveCeutical Medical Inc. (the "Company" or "PreveCeutical") (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H), is proud to announce that Endosane.

British columbiaUnited statesFrankfurt am mainBaden wübergStephen van deventerFabian friedeCentral institute of mental health mannheimF markus leweke university of sydneyRegulation services providerCentre of the university sydneySanity groupEndosane pharmaceuticals gmbPreveceutical medical incEndosane pharmaceuticalsPsychotherapy researchCanadian securities exchange

PreveCeutical Enters into License Option Agreement with Endosane Pharmaceuticals

PreveCeutical Enters into License Option Agreement with Endosane Pharmaceuticals
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesUnited kingdomBritish columbiaFrankfurt am mainBaden wübergFabian friedeStephen van deventerSanity groupEndosane pharmaceuticalsPsychotherapy researchBritish columbia newsfile corpPreveceutical medical incCompany or preveceuticalNeither the canadian securities exchangeF markus leweke university of sydneyCanadian securities exchange

2023-01-12 | CSE:PREV | Press Release | PreveCeutical Medical Inc

(2023-01-12 | CSE:PREV) PreveCeutical Enters into License Option Agreement with Endosane Pharmaceuticals

United statesUnited kingdomBritish columbiaFrankfurt am mainBaden wübergFabian friedeStephen van deventerSanity groupEndosane pharmaceuticalsPsychotherapy researchBritish columbia newsfile corpPreveceutical medical incCompany or preveceuticalNeither the canadian securities exchangeF markus leweke university of sydneyCanadian securities exchange

PreveCeutical Medical Inc : PreveCeutical Enters into License Option Agreement with Endosane Pharmaceuticals

Vancouver, British Columbia (Newsfile Corp. - January 12, 2023) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) (the "Company" or "PreveCeutical"), is pleased to announce that it has

United statesUnited kingdomBritish columbiaFrankfurt am mainBaden wübergFabian friedeStephen van deventerSanity groupEndosane pharmaceuticalsPsychotherapy researchBritish columbia newsfile corpPreveceutical medical incCompany or preveceuticalNeither the canadian securities exchangeF markus leweke university of sydneyCanadian securities exchange